These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
504 related items for PubMed ID: 19091671
1. [Prophylaxis and treatment of chronic viral hepatitis as the prevention of hepatocellular carcinoma]. Pár A. Orv Hetil; 2009 Jan 04; 150(1):19-26. PubMed ID: 19091671 [Abstract] [Full Text] [Related]
2. [Strategies for the prevention of hepatocellular carcinoma in the context of chronic viral hepatitis]. Schott E, Bergk A, Berg T. Z Gastroenterol; 2008 Jan 04; 46(1):69-80. PubMed ID: 18188819 [Abstract] [Full Text] [Related]
3. Prevention of hepatocellular carcinoma in the Asia-Pacific region: consensus statements. Asia-Pacific Working Party on Prevention of Hepatocellular Carcinoma. J Gastroenterol Hepatol; 2010 Apr 04; 25(4):657-63. PubMed ID: 20492323 [Abstract] [Full Text] [Related]
4. Prevention of hepatocellular carcinoma in hepatitis B virus infection. Lim SG, Mohammed R, Yuen MF, Kao JH. J Gastroenterol Hepatol; 2009 Aug 04; 24(8):1352-7. PubMed ID: 19702903 [Abstract] [Full Text] [Related]
5. Prevention and surveillance of hepatitis B virus-related hepatocellular carcinoma. Liaw YF. Semin Liver Dis; 2005 Aug 04; 25 Suppl 1():40-7. PubMed ID: 16103980 [Abstract] [Full Text] [Related]
6. Prevention of hepatocellular carcinoma in patients with chronic hepatitis B virus infection. Kim BK, Han KH, Ahn SH. Oncology; 2011 Aug 04; 81 Suppl 1():41-9. PubMed ID: 22212935 [Abstract] [Full Text] [Related]
7. Oncogenic viruses and hepatocellular carcinoma. Ben Ari Z, Weitzman E, Safran M. Clin Liver Dis; 2015 May 04; 19(2):341-60. PubMed ID: 25921667 [Abstract] [Full Text] [Related]
8. Does antiviral therapy for hepatitis B and C prevent hepatocellular carcinoma? Lok AS. J Gastroenterol Hepatol; 2011 Feb 04; 26(2):221-7. PubMed ID: 21070361 [Abstract] [Full Text] [Related]
10. Prevention of hepatocellular carcinoma: beyond hepatitis B vaccination. Kim MN, Han KH, Ahn SH. Semin Oncol; 2015 Apr 04; 42(2):316-28. PubMed ID: 25843736 [Abstract] [Full Text] [Related]
11. [The prophylaxis of hepatocellular carcinoma by interferon-alpha in virus-induced cirrhosis]. Merle P, Zoulim F, Vitvitski L, Trépo C. Gastroenterol Clin Biol; 2000 Dec 04; 24(12):1166-76. PubMed ID: 11173729 [No Abstract] [Full Text] [Related]
12. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma. Durazo FA, Blatt LM, Corey WG, Lin JH, Han S, Saab S, Busuttil RW, Tong MJ. J Gastroenterol Hepatol; 2008 Oct 04; 23(10):1541-8. PubMed ID: 18422961 [Abstract] [Full Text] [Related]
14. Utility of alpha-fetoprotein (AFP) in the screening of patients with virus-related chronic liver disease: does different viral etiology influence AFP levels in HCC? A study in 350 western patients. Cedrone A, Covino M, Caturelli E, Pompili M, Lorenzelli G, Villani MR, Valle D, Sperandeo M, Rapaccini GL, Gasbarrini G. Hepatogastroenterology; 2000 Oct 04; 47(36):1654-8. PubMed ID: 11149026 [Abstract] [Full Text] [Related]
18. Prevention of hepatocellular carcinoma in chronic viral hepatitis B and C infection. Lu T, Seto WK, Zhu RX, Lai CL, Yuen MF. World J Gastroenterol; 2013 Dec 21; 19(47):8887-94. PubMed ID: 24379612 [Abstract] [Full Text] [Related]
19. Role of antiviral therapy in the management of hepatocellular carcinoma. Guan YS, He Q. Anticancer Drugs; 2013 Apr 21; 24(4):337-43. PubMed ID: 23388161 [Abstract] [Full Text] [Related]